Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Johns

Showing results (191-200 of 207) with videos related to

Pageof 21
Sort By:
The Journal of Physical Chemistry Letters|August 14, 2015
Trapping of Mobile Pt Species by PdO Nanoparticles under Oxidizing ConditionsCristihan Carrillo, Tyne R Johns, Haifeng Xiong, et al.
Neurobiology of Aging|October 26, 2005
Somatic mitochondrial DNA mutations in single neurons and gliaIppolita Cantuti-Castelvetri, Michael T Lin, Kangni Zheng, et al.
The Journal of General Physiology|April 20, 2023
Allosteric modulation of GluN1/GluN3 NMDA receptors by GluN1-selective competitive antagonistsNirvan Rouzbeh, Andrew R Rau, Avery J Benton, et al.
Neurobiology of Aging|December 29, 2009
Metabotropic glutamate receptor type 5 in levodopa-induced motor complicationsBazoumana Ouattara, Laurent Grégoire, Marc Morissette, et al.
Neurobiology of Aging|December 17, 2003
Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's diseaseDavid K Simon, Michael T Lin, Leiya Zheng, et al.
Molecular Pharmacology|February 25, 2026
UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptorsAvery J Benton, Mia R Johns, Emil Diamant, et al.
Neurogenetics|May 21, 2003
A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystoniaDavid K Simon, Jennifer Friedman, Xandra O Breakefield, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptorsAvery J Benton, Mia R Johns, Emil Diamant, et al.
Pediatric Research|November 1, 1990
Heteroplasmy in chronic external ophthalmoplegia: clinical and molecular observationsO Hurko, D R Johns, S L Rutledge, et al.
Antiviral Chemistry & Chemotherapy|January 6, 1999
The design, synthesis and properties of highly potent and selective inhibitors of herpes simplex virus types 1 and 2 thymidine kinaseJ A Martin, G J Thomas, J H Merrett, et al.
Pageof 21

Showing results (191-200 of 207) with videos related to

Sort By:
Pageof 21
The Journal of Physical Chemistry Letters|August 14, 2015
Trapping of Mobile Pt Species by PdO Nanoparticles under Oxidizing ConditionsCristihan Carrillo, Tyne R Johns, Haifeng Xiong, et al.
Neurobiology of Aging|October 26, 2005
Somatic mitochondrial DNA mutations in single neurons and gliaIppolita Cantuti-Castelvetri, Michael T Lin, Kangni Zheng, et al.
The Journal of General Physiology|April 20, 2023
Allosteric modulation of GluN1/GluN3 NMDA receptors by GluN1-selective competitive antagonistsNirvan Rouzbeh, Andrew R Rau, Avery J Benton, et al.
Neurobiology of Aging|December 29, 2009
Metabotropic glutamate receptor type 5 in levodopa-induced motor complicationsBazoumana Ouattara, Laurent Grégoire, Marc Morissette, et al.
Neurobiology of Aging|December 17, 2003
Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's diseaseDavid K Simon, Michael T Lin, Leiya Zheng, et al.
Molecular Pharmacology|February 25, 2026
UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptorsAvery J Benton, Mia R Johns, Emil Diamant, et al.
Neurogenetics|May 21, 2003
A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystoniaDavid K Simon, Jennifer Friedman, Xandra O Breakefield, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptorsAvery J Benton, Mia R Johns, Emil Diamant, et al.
Pediatric Research|November 1, 1990
Heteroplasmy in chronic external ophthalmoplegia: clinical and molecular observationsO Hurko, D R Johns, S L Rutledge, et al.
Antiviral Chemistry & Chemotherapy|January 6, 1999
The design, synthesis and properties of highly potent and selective inhibitors of herpes simplex virus types 1 and 2 thymidine kinaseJ A Martin, G J Thomas, J H Merrett, et al.
Pageof 21